MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    A Rare Case of Hemicorea Secondary to Giant Perivascular Space: A Case Report

    M. Merscher, C. Lobo, V. de Souza, R. Souza, R. Helmer, L. Pinho, L. Urzeda, W. Machado-Filho, T. Ganho, W. Avelar (Campinas, Brazil)

    Objective: To describe a rare cause of unilateral chorea caused by a structural lesion with few descriptions in literature. Background: While chorea typically manifests in…
  • 2024 International Congress

    The Impact of Standardized Recommendations on the Management of Initial and Refractory Pediatric Status Dystonicus

    K. Yang, N. Alazri, L. Vogt, Z. Zaman, V. Quiroz, C. Gorodetsky, D. Ebrahimi-Fakhari (Boston, USA)

    Objective: To develop consensus recommendations for the assessment, triaging and management of pre-status dystonicus, status dystonicus, and refractory status dystonicus in children. Background: Status dystonicus…
  • 2024 International Congress

    Dystonia and Impact on Employment in a Spanish Cohort

    E. Casas, E. Cañada, R. Berbegal, S. Lozano, G. Cabañas, N. Mena, M. Campos, R. Pastor, A. Patiño, I. Muro, L. Lopez-Manzanares, A. Alonso-Canovas (Madrid, Spain)

    Objective: To evaluate the effect of age at diagnosis, impact on social and family life, and complications of dystonia (such as inability to communicate correctly…
  • 2024 International Congress

    Phenotypic Variability in Combined Parkinsonism-Dystonia and Isolated Idiopathic Dystonia

    S. Idrissi, A. Trinchillo, V. Velucci, R. Pellicciari, M. Esposito, D. Belvisi, G. Fabbrini, R. Erro, C. Terranova, M. Zibetti, MC. Altavista, MS. Cotelli, A. Castagna, P. Barbero, D. Cassano, MM. Mascia, T. Ercoli, L. Magistrello, T. Schirinzi, M. Tinazzi, A. Pisani, L. Marinelli, A. Berardelli, G. Defazio (Bari, Italy)

    Objective: To analyze the demographic and clinical differences between patients with combined parkinsonism-dystonia and those with isolated idiopathic dystonia. Background: The current dystonia classification system…
  • 2024 International Congress

    Increased cerebellar grey matter in writer’s cramp patients: a morphometric signature of symptom compensation

    K. Witt, V. Yogeswaran, J. Stalter, A. Knutzen, A. Baumann, K. Zeuner (Oldenburg, Germany)

    Objective: This study focused on grey matter changes in the cerebellum by performing voxel-based morphometry (VBM) on infratentorial MRI scans of writers' cramp (WC) patients,…
  • 2024 International Congress

    Study of Relationship Between Homocysteine, Folic Acid And Vitamin B12 Levels In Serum of Juvenile HD Children.

    A. Kumar, P. Mishra (Delhi, India)

    Objective: Our objective is to estimate the level of Hcy ,vitamin B12 , folic acid with motor and non-motor symptoms in HD patients in school…
  • 2024 International Congress

    Sustained Chorea Improvements with Long-Term, Once-Daily Valbenazine in Adults with Huntington’s Disease

    E. Furr Stimming, D. Claassen, E. Kayson, J. Goldstein, R. Mehanna, S. Hinton, O. Klepitskaya, H. Zhang, E. Dunayevich, G. Liang, D. Haubenberger (Houston, USA)

    Objective: To present interim analyses from KINECT®-HD2 (NCT04400331), an ongoing open-label study of once-daily valbenazine (VBZ) for chorea associated with Huntington’s disease (HD). Background: In…
  • 2024 International Congress

    Huntington’s Disease Pathogenesis, Molecular Factors, and Potential for Combinatorial Therapies: A Focus on BDNF and NMDA Receptor Therapies

    M. Mistry, J. Pace, E. Guivatchian, J. Hinman (Fort Worth, USA)

    Objective: This paper outlines current therapeutic options for HD, and ultimately suggests taking a combinatorial therapeutic approach to slow HD progression by simultaneously treating multiple…
  • 2024 International Congress

    Serum Alpha-Synuclein Levels Are Decreased in Patients with Restless Legs Syndrome and Restored by Intravenous Iron Therapy in Correlation with Ferritin

    A. Tahanis, V. Hashem, W. Ondo (Houston, USA)

    Objective: To determine potential connection between serum Alpha-synuclein (α-syn) concentrations and restless legs syndrome (RLS), and explore the impact of intravenous (IV) iron supplementation on serum…
  • 2024 International Congress

    Impact of Patient Input on the Study Execution of a Prospective, Epidemiological Study

    R. Zorowitz, L. Barrenechea, S. Butet, S. Groppa, D. Herrero, R. Prasad, S. Sandars, P. Maisonobe, S. Page, A. Picelli (Washington, USA)

    Objective: To demonstrate the direct impact patient input had on the study design and execution of the Epitome study (NCT06055725). Background: It is increasingly accepted…
  • « Previous Page
  • 1
  • …
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley